Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Significant alterations in the structure and cellular composition of the distal lung are a defining characteristic of pulmonary fibrosis (PF); however, the specific spatial contexts that play a role ...

Hepatic fibrosis is a reversible wound healing response characterized by accumulation of extracellular matrix (ECM), or "scar," that follows chronic but not self-limited liver disease. The ECM ...

Key findings include: AI-assisted digital pathology 49.2% (p=0.02 vs placebo) of 600 mg treated patients achieving a ≥1-stage improvement in fibrosis versus 25.7% of placebo treated patients as ...

The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot ... lesions in the pathology of NASH, including ...

In late-stage DAD, the researchers saw an increase of markers associated with lung fibrosis—a lung pathology that causes scarring and stiffness in lung tissue, making it difficult to breathe.

Tribune raises EUR 37 million in seed and Series A funding to advance portfolio of therapies targeting central drivers of ...